http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012025261-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ccb1037a098f61eaecd60c1f10d6a53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddcb273a108a5d8472b335280098e06
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1089
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05H7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1042
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
filingDate 2011-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfe646307259adbe8009a8a0cfaf643b
publicationDate 2012-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012025261-A1
titleOfInvention Therapy device
abstract The invention relates to a combined electron and X-ray therapy device. The therapy device comprises a beam head which can be rotated about an axis of rotation and in which an electron beam device for producing an electron beam field and an X-ray device for producing an X-ray field are located. In the operational state both beam fields can be directed onto a target volume, for example a patient's tumour. Both beam devices comprise a separate electron accelerator which is optimised for the particular mode of operation. The RF power required for operating the accelerator is provided by a common RF source which is connected to both accelerators via a diverter. Depending upon the mode of operation, the diverter guides the RF power provided onto the particular accelerator.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576303-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021023397-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679280-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485991-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016193482-A1
priorityDate 2010-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4726046-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5372477
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39353

Total number of triples: 29.